Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
Age-related macular degeneration (AMD) is a growing public health concern given the aging population and it is the leading cause of blindness in developed countries, affecting individuals over the age of 55 years. AMD affects the retinal pigment epithelium (RPE) and Bruch’s membrane in the macula, l...
主要な著者: | Borchert, GA, Shamsnajafabadi, H, Ng, BWJ, Xue, K, De Silva, SR, Downes, SM, MacLaren, RE, Cehajic-Kapetanovic, J |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
Frontiers Media
2024
|
類似資料
-
Age-related macular degeneration: suitability of optogenetic therapy for geographic atrophy
著者:: Grace A. Borchert, 等
出版事項: (2024-07-01) -
The Role of Inflammation in Age-Related Macular Degeneration—Therapeutic Landscapes in Geographic Atrophy
著者:: Grace A. Borchert, 等
出版事項: (2023-08-01) -
Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances
著者:: Michelle E. McClements, 等
出版事項: (2020-11-01) -
Real-world six-month outcomes in patients switched to faricimab following partial response to anti-VEGF therapy for neovascular age-related macular degeneration and diabetic macular oedema
著者:: Borchert, GA, 等
出版事項: (2024) -
Current and Future Landscape in Genetic Therapies for Leber Hereditary Optic Neuropathy
著者:: Hoda Shamsnajafabadi, 等
出版事項: (2023-08-01)